Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Colorcon
Covington
AstraZeneca
US Department of Justice
Moodys
Medtronic
UBS
Merck
Deloitte

Generated: January 23, 2018

DrugPatentWatch Database Preview

COLY-MYCIN S Drug Profile

« Back to Dashboard

Which patents cover Coly-mycin S, and what generic alternatives are available?

Coly-mycin S is a drug marketed by Endo Pharms Inc and Parke Davis and is included in two NDAs.

The generic ingredient in COLY-MYCIN S is colistin sulfate. There are four drug master file entries for this compound. Additional details are available on the colistin sulfate profile page.
Summary for COLY-MYCIN S
Drug patent expirations by year for COLY-MYCIN S
Pharmacology for COLY-MYCIN S
Medical Subject Heading (MeSH) Categories for COLY-MYCIN S

US Patents and Regulatory Information for COLY-MYCIN S

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Endo Pharms Inc COLY-MYCIN S colistin sulfate; hydrocortisone acetate; neomycin sulfate; thonzonium bromide SUSPENSION/DROPS;OTIC 050356-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Parke Davis COLY-MYCIN S colistin sulfate SUSPENSION;ORAL 050355-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Fish and Richardson
AstraZeneca
Chubb
Boehringer Ingelheim
Queensland Health
Baxter
Julphar
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot